; and (B) an analysis of the appropriateness of expanding or extending the demonstration project or implementing a new methodology for payment for intravenous immune globulins in all care settings under part B of title XVIII of the Social Security Act ( 42 U.S.C. 1395k et seq.) and, to the extent such analysis determines such an expansion, extension, or methodology appropriate, recommendations for such expansion, extension, or methodology, respectively. (2) Final evaluation and report Not later than one year after the date of completion of the demonstration project, the Secretary shall submit to Congress a report that contains— (A) a final evaluation of the impact described in paragraph (1)(A); and (B) a final analysis and recommendations described in paragraph (1)(B). (g) Definitions In this section: (1) Demonstration project The term demonstration project means the demonstration project conducted under this Act. (2) Medicare beneficiary The term Medicare beneficiary means an individual who is enrolled for benefits under part B of title XVIII of the Social Security Act.